No connection

Search Results

BW

BEARISH
$10.51 Live
Babcock & Wilcox Enterprises, Inc. · NYSE
Target $14.5 (+38.0%)
$0.22 52W Range $14.9

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 16, 2026
Market cap
$1.37B
P/E
N/A
ROE
N/A
Profit margin
-6.2%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
BW exhibits severe financial distress signals with a Piotroski F-Score of 0/9, indicating extreme operational and financial weakness. The absence of an Altman Z-Score and negative Price/Book ratio (-10.42) suggest deep value distortion and potential insolvency risk. Despite a strong 1-year return of +991.4%, the company reports a negative profit margin (-6.16%) and declining revenue (YoY -19.8%), undermining long-term sustainability. Insider selling of $10.4M in a single transaction further undermines confidence. The stock trades at a premium to its intrinsic value due to speculative growth expectations, but these are not supported by fundamentals.

Key Strengths

Recent quarterly earnings have shown significant positive surprises (e.g., +418.1% in Q3 2025)
Strong analyst consensus with a 'strong_buy' recommendation from 4 analysts
Significant 1-year price appreciation (+991.4%) indicates strong market momentum
Positive Q/Q EPS growth of +166.7% suggests recent earnings recovery
High average earnings surprise (41.26%) in the last 4 quarters reflects potential for upside volatility

Key Risks

Piotroski F-Score of 0/9 indicates severe financial distress and operational failure across all nine criteria
Negative profit margin (-6.16%) and declining revenue (-19.8% YoY) signal deteriorating business fundamentals
Insider selling of 1.15M shares worth $10.4M signals lack of confidence from within the company
No available Altman Z-Score with negative Price/Book (-10.42) raises bankruptcy risk concerns
Lack of reliable valuation metrics (P/E, PEG, ROE, FCF) limits analytical confidence

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
24
Weak
Value
20
Future
50
Past
40
Health
10
Dividend
0
AI Verdict
Weak
Key drivers: Piotroski F-Score of 0/9, Negative profit margin and revenue decline, Insider selling activity, Absence of key financial health metrics, High speculative price momentum without earnings support
Confidence
85%
Value
20/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Sales of 2.33 is below sector average (avg 58.21% margin suggests high valuation elsewhere)
  • Recent strong earnings surprises may justify premium valuation
Watchpoints
  • No Graham Number or intrinsic value estimate available
  • Negative Price/Book (-10.42) implies market value is below book value, which is abnormal for a healthy firm
  • Forward P/E of 26.06 is high relative to negative earnings and declining revenue
Future
50/100

Ref Growth rates

Positives
  • Recent Q/Q EPS growth of +166.7% suggests potential turnaround
  • Strong analyst target price of $14.50 implies growth optimism
Watchpoints
  • Revenue growth is sharply negative (-19.8% YoY)
  • Forward P/E is based on uncertain earnings projections
  • No reliable EBITDA or FCF data to assess future cash generation
Past
40/100

Ref Historical trends

Positives
  • Historical earnings surprises have been large and positive (e.g., +418.1% in Q3 2025)
  • Some quarters show strong performance (e.g., $0.33 actual vs $-0.10 estimate)
Watchpoints
  • Multiple quarters with massive negative surprises (e.g., -7233.9% in Q3 2023)
  • Persistent losses and declining margins over multiple years
  • Most recent Q/Q EPS growth is -93.9%, indicating deterioration
Health
10/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Operating margin is positive (3.29%)
  • Current ratio of 1.22 is above 1.0
Watchpoints
  • Piotroski F-Score of 0/9 indicates complete failure on financial health criteria
  • No available Altman Z-Score, but negative Price/Book and negative ROA (1.18%) suggest distress
  • Quick ratio of 0.73 is below 1.0, indicating liquidity strain
  • No data on debt, cash, or ROIC, limiting health assessment
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend yield and payout ratio are both 0.00%
  • No history of dividend payments
  • Negative earnings make dividend sustainability impossible

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$10.51
Analyst Target
$14.5
Upside/Downside
+38.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BW and closest competitors.

Updated 2026-03-13
BW
Babcock & Wilcox Enterprises, Inc.
Primary
5Y
+38.8%
3Y
+93.9%
1Y
+991.4%
6M
+278.1%
1M
+9.4%
1W
-19.8%
ENR
Energizer Holdings, Inc.
Peer
5Y
-51.5%
3Y
-31.0%
1Y
-22.3%
6M
-15.5%
1M
+19.4%
1W
-2.4%
ARL
Arlo Technologies, Inc.
Peer
5Y
+60.2%
3Y
+244.6%
1Y
+8.2%
6M
-20.0%
1M
-7.4%
1W
-7.8%
ALG
Allegiant Travel Company
Peer
5Y
-71.1%
3Y
-15.9%
1Y
+40.3%
6M
+15.9%
1M
-31.4%
1W
-5.6%
DLX
Deluxe Corporation
Peer
5Y
-9.8%
3Y
+147.2%
1Y
+108.4%
6M
+61.0%
1M
+8.5%
1W
-0.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
26.06
PEG Ratio
N/A
P/B Ratio
-10.42
P/S Ratio
2.33
EV/Revenue
2.81
EV/EBITDA
71.13
Market Cap
$1.37B

Profitability

Profit margins and return metrics

Profit Margin -6.16%
Operating Margin 3.29%
Gross Margin 24.48%
ROE N/A
ROA 1.18%

Growth

Revenue and earnings growth rates

Revenue Growth -19.8%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
1.22
Good
Quick Ratio
0.73
Poor
Cash/Share
$0.69

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-04
$N/A
2026-03-04
$0.02
+134.4% surprise
2025-11-04
$0.33
+418.1% surprise
2025-08-11
$-0.58
-428.7% surprise

Industrials Sector Comparison

Comparing BW against 469 companies in the Industrials sector (39 bullish, 174 neutral, 256 bearish)
Profit Margin
-6.16%
This Stock
vs
6.65%
Sector Avg
-192.6% (Weaker)
Revenue Growth
-19.8%
This Stock
vs
71.29%
Sector Avg
-127.8% (Slower)
Current Ratio
1.22
This Stock
vs
3.09
Sector Avg
-60.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DZIEWISZ JOHN JOSEPH
General Counsel
Option Exercise
2026-03-05
75,000 shares · $996,750
FRYMYER CAMERON M
Chief Financial Officer
Option Exercise
2026-03-05
75,000 shares · $996,750
BRC GROUP HOLDINGS, INC.
Beneficial Owner of more than 10% of a Class of Security
Sell
2026-02-11
1,155,382 shares · $10,398,438
BARTOLI HENRY E
Director
Option Exercise
2025-11-21
85,000 shares · $516,800
FRYMYER CAMERON M
Chief Financial Officer
Buy
2025-11-12
2,853 shares · $20,114
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
4 analysts
Northland Capital Markets
2026-01-22
init
Outperform
DA Davidson
2025-11-12
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning BW from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile